| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |